ANGIODYNAMICS - Key Persons
Job Titles:
- Senior Vice President, Business Development
- Senior Vice President, Business Development, Strategy and R & D
Benjamin H. Davis joined AngioDynamics as Senior Vice President, Business Development, Strategy and R&D in March 2015. Prior to joining AngioDynamics, Mr. Davis most recently was the Vice President of Business Integration at C.R. Bard, Inc. where he also served as the Divisional Head of Business Development from 2004-2013. Before joining C.R. Bard, Inc., Mr. Davis held the position of Chief Financial Officer and Treasurer at Axya Medical Inc. He holds a Bachelor of Science in Business Administration from Bryant College and Master in Business Administration in Finance from Bentley University Graduate School of Business.
Job Titles:
- Senior Vice President and General Manager, Oncology and Vascular Access
- Senior Vice President and General Manager, Vascular Access
Chad T. Campbell joined AngioDynamics in May 2016. He is the Senior Vice President and General Manager for AngioDynamics' Oncology and Vascular Access Global Business Units. In his role, Mr. Campbell oversees research and development and global commercialization of Oncology and Vascular Access GBU portfolios. Mr. Campbell joined AngioDynamics from Medtronic where he served as the Vice President of Marketing for the Patient Care and Safety business after serving as the Vice President of Marketing for the SharpSafety business at Covidien (Medtronic). During his tenure at Covidien, Mr. Campbell also held roles including Director of Marketing, Area Vice President of Sales, Region Manager, Product Manager and Account Manager. Mr. Campbell received a Bachelor of Arts from the University of Kentucky.
Job Titles:
- Senior Vice President, Global Operations
- Senior Vice President of Global Operations and R & D
- Senior Vice President, Global Operations and Supply Chain
David D. Helsel currently serves as Senior Vice President, Global Operations and Supply Chain and has been with AngioDynamics since December 2017. Prior to joining AngioDynamics he was Senior Vice President, Global Supply Chain, at Hill-Rom Holdings for almost three years. Before that, Mr. Helsel worked at Haemontiecs for three years where he served as Executive Vice President for Global Manufacturing and also spent almost nineteen years in various positions with increasing responsibility at Covidien, including Vice President of Operations for the Surgical Solutions Division and Medical Supplies Division. An expert in Lean and Six Sigma, Mr. Helsel also served as Global Director of Operational Excellence, supporting sixty-three manufacturing facilities. Mr. Helsel holds a Bachelor of Science in Mechanical Engineering from LeTourneau University.
Job Titles:
- Chairman of the Audit Committee
- Director
- Member of the Compensation Committee
- Audit Committee
- President and Chief Executive Officer of Cygnus Manufacturing Company LLC
Dennis S. Meteny joined the AngioDynamics Board of Directors in March 2004. Mr. Meteny is President and Chief Executive Officer of Cygnus Manufacturing Company LLC, a privately held manufacturer of minimally- and non-invasive medical device products; health and safety components; and high-precision transportation, aerospace and industrial products. From 2003-06, Mr. Meteny was an Executive-in-Residence at the Pittsburgh Life Sciences Greenhouse, a strategic economic development initiative of the University of Pittsburgh Health System, Carnegie Mellon University, the University of Pittsburgh, the state of Pennsylvania and local foundations. From 2001-03 he was President and Chief Operating Officer of TissueInformatics Inc., a privately-held company engaged in the medical imaging business. From 2000-01, Mr. Meteny was a business consultant to various technology companies. Prior to that, Mr. Meteny spent 15 years in several executive-level positions, including as President and Chief Executive Officer from 1994-99, of Respironics Inc., a cardio-pulmonary medical device company. Mr. Meteny holds a B.S. in accounting from The Pennsylvania State University and an M.B.A. from the University of Pittsburgh.
Chair of the Audit Committee
Member of the Compensation Committee
Job Titles:
- Chairman of the Compensation Committee
- Director
- Member of the Audit Committee
- Executive Chairman of Helios
Eileen Auen most recently served as Executive Chairman of Helios, a $1 billion healthcare services firm formed by the merger of PMSI and Progressive Medical in 2013. Prior roles include Chairman and Chief Executive Officer of PMSI, Head of Healthcare Management at Aetna, and Chief Executive Officer of APS Healthcare. She currently provides consulting services to the healthcare industry through Deep Run Consulting, a firm she founded. Ms. Auen earned a bachelor's degree in Economics and Finance from Towson University, and an M.B.A. from the University of Virginia School of Business. Ms. Auen currently serves as the Lead Director for ICF International (NASDAQ:ICFI). She also serves as a member of the Board of Directors for Medstar Union Memorial Hospital and Tufts Health Plan.
Chair of the Compensation Committee
Member of the Nominating, Compliance, and Corporate Governance Committee
Howard W. Donnelly joined the AngioDynamics Board of Directors in March 2004 and is the President of Concert Medical LLC, a manufacturer of interventional medical devices. In addition, Mr. Donnelly is President and Chief Executive Officer of HydroCision Inc., a medical device manufacturer focused on the spine market. From 1999 to 2002, he was President of Level 1 Inc., a medical device manufacturer and a subsidiary of Smiths Group. From 1990-99, Mr. Donnelly was employed at Pfizer Inc., with his last position being Vice President, Business Planning and Development, for Pfizer's Medical Technology Group from 1997-99.
Job Titles:
- Director
- Member of the Audit Committee
- Audit Committee
Jan Reed was most recently Senior Vice President, General Counsel and Corporate Secretary at Walgreens Boots Alliance, Inc., a global pharmacy-led, health and wellbeing enterprise with annual revenues in excess of $115 billion. Prior to this role, Ms. Reed also served as Executive Vice President of Human Resources, General Counsel and Corporate Secretary of Solo Cup Company, and Associate General Counsel, Corporate Secretary and Chief Governance Officer at Baxter International Inc. Ms. Reed earned a Bachelor of Arts degree, with honors, in Psychology from the University of Michigan, and a Juris Doctor from Northwestern University School of Law. Ms. Reed currently serves as a member of the Board of Directors for Stepan Company (NYSE:SCL).
Member of the Audit Committee
Member of the Nominating, Compliance, and Corporate Governance Committee
Job Titles:
- Chief Executive Officer
- Director
- Member of the Management Team
- President
Jim Clemmer became our President and Chief Executive Officer in April 2016. Prior to joining AngioDynamics, Mr. Clemmer served as President…
President and Chief Executive Officer Jim Clemmer joined AngioDynamics in April 2016, bringing more than 25 years of leadership within the healthcare industry and a proven track record of success.
Prior to AngioDynamics, Clemmer served as president of the $1.8 billion medical supplies segment at Covidien plc., where he directed strategic and day-to-day operations for global business divisions that collectively manufactured 23 different product categories. In addition, he managed global manufacturing, research and development, operational excellence, business development and all other functions associated with the medical supplies business. Prior to his role at Covidien, Clemmer served as group president at Kendall Healthcare, where he managed the US business across five divisions and built the strategic plan for the Medical Supplies segment before it was spun off from Tyco. Clemmer began his career at Sage Products, Inc.
Clemmer currently serves on the Board of Directors for AngioDynamics and Lantheus Medical Imaging. Clemmer is a graduate of the Massachusetts College of Liberal Arts.
Job Titles:
- Senior Vice President
- Senior Vice President of Scientific and Clinical Affairs
Juan Carlos Serna moved into the role of Senior Vice President of Scientific and Clinical Affairs (S&CA) in December 2020. Mr. Serna leads our global Clinical Affairs and Services, Medical Affairs, Physician Education, and Healthcare Economics teams as they work to advance scientific research and patient access to AngioDynamics' technologies and devices. Mr. Serna brings more than 20 years of experience to this role, leading FDA-regulated companies through preclinical, clinical, reimbursement, and regulatory transformations. Mr. Serna joined AngioDynamics in 2017 as Vice President of Global Clinical Affairs and Healthcare Economics. In previous roles, he founded and developed the core technology behind Right Submission, a web-based regulatory submission platform for the medical device industry, and served as president of a medical device clinical and regulatory consulting firm. He received his B.A.in Biology and Philosophy from Dartmouth College and an MBA from Franklin W. Olin Graduate School of Business at Babson College.
Job Titles:
- Director
- Member of the Audit Committee
- Member of the Compensation Committee
- Audit Committee
- Company 's Board of Director
Karen Licitra joined the Company's Board of Director's in July 2019. From January 2014 through August 2015, Ms. Licitra served as Corporate Vice President, Worldwide Government Affairs & Policy at Johnson & Johnson, a medical device, pharmaceutical, and consumer packaged goods manufacturer. From December 2011 to December 2013, Ms. Licitra served as the Worldwide Chairman, Global Medical Solutions at Johnson & Johnson. From July 2002 to November 2011, she served as the Company Group Chairman and Worldwide Franchise Chairman at Ethicon Endo-Surgery, Inc., a Johnson & Johnson medical device company. From January 2001 to June 2002, she served as the President of Ethicon Endo-Surgery. Ms. Licitra has been a member of the board of directors of Si-Bone, Inc. (Nasdaq: SIBN) since August 2015. Ms. Licitra earned a Bachelor of Science degree in Commerce from Rider College.
Member of the Compensation Committee
Member of the Audit Committee
Job Titles:
- Head of the AngioDynamics' IT
- Senior Vice President of IT
Kim L. Seabury became the head of the AngioDynamics' IT group in September 2011. Prior to joining AngioDynamics, Mrs. Seabury served as Vice President of Emerging Technologies and Product Development for Pitney Bowes Software, managing global software development teams for both core products and emerging SaaS solutions. Prior to her role at Pitney Bowes, Mrs. Seabury held several key leadership positions at MapInfo Corporation, including Global Managing Director of IT, IT Business Applications Director and Director of Web Operations. Mrs. Seabury is certified in PSI, Operational Excellence, ITIL and is a Six-Sigma Green Belt. In addition, Mrs. Seabury has extensive experience in project management and has participated in a variety of leadership development programs. Mrs. Seabury holds a Bachelor of Science degree in Applied Arts and Science from Rochester Institute of Technology.
Job Titles:
- General Manager
- Senior Vice President
- Senior Vice President and General Manager for International
Laura Piccinini joined AngioDynamics as Senior Vice President and General Manager for International in June 2021. Ms. Piccinini brings more than 25 years of experience in leadership roles in the Medical Device/Technology industry, with an extensive background in the field of respiratory care. Most recently, she served as CEO & member of the Board of Directors for Respiratory Motion, Inc., and was Global Head of Commercial Operations for the Implants business unit at Nobel Biocare Systems (Danaher Company/Envista IPO). Earlier in her career, Ms. Piccinini served as President of EMEA at both Covidien and Stryker. Ms. Piccinini is a graduate of the Parma University of Medicine, where she received a nursing degree with specializations in ICU, Anesthesia, and First Aid as a Helicopter Flight Coordinator.
Job Titles:
- Director
- Member of the Audit Committee
- Member of the Compensation Committee
- Audit Committee
Ms. Burgess was most recently Chief Financial Officer and Vice President of Finance for the Americas Region at Medtronic, Inc., a Fortune 200 global medical device company with more than $30 billion in annual revenues. Prior to this role, Ms. Burgess also served as Vice President of Customer Care for the Americas and Western Europe at Medtronic, Inc. and Vice President of Finance for the Cardiovascular Group's Sales and Marketing function.
Ms. Burgess earned a Bachelor of Arts in Communication and Political Science from the University of Michigan and a Master's in Business Administration from Ohio State University. Ms. Burgess is a member of the Board of Directors for Stepan Company.
Member of the Audit Committee
Member of the Compensation Committee
Job Titles:
- Senior Vice President of Human Resources
Marna I. Bronfen-Moore joined AngioDynamics as the Senior Vice President of Human Resources in September 2019 bringing with her over 20…
Job Titles:
- Director
- Member of the Audit Committee
Since June 2019, Dr. Tarnoff has been Chair of the Department of Surgery and Surgeon-in-Chief at Tufts Medical Center and Tufts University School of Medicine in Boston, Massachusetts. Dr. Tarnoff has been a surgeon at Tufts since 2001. Dr. Tarnoff was Chief Medical Officer at Medtronic from January 2015 through August 2019. From 2008 until its acquisition by Medtronic in 2015, Dr. Tarnoff served as the Chief Medical Officer and Senior Vice President for Medical Affairs at Covidien plc. Dr. Tarnoff received a BA in psychology from Washington University in St Louis, and received an MD from and completed his residency in General Surgery at the University and Medicine and Dentistry of New Jersey. Dr. Tarnoff also completed a fellowship in Advanced Minimally Invasive Surgery at the Cleveland Clinic in Cleveland, Ohio.
Member of the Nominating, Compliance, and Corporate Governance Committee
Job Titles:
- Director of Communications
- Vice President, Communications
- Our Director of Communications
Saleem M. Cheeks joined AngioDynamics as our Director of Communications in February 2018, becoming Vice President, Communications in February 2020. Prior to joining AngioDynamics, and bringing with him more than 16 years of private and public-sector experience in communications, community relations, and politics, Mr. Cheeks served as a key member of the Mower public affairs practice, where he advised global corporations and non-profits, and developed award-winning communications strategies for major economic development projects. Prior to his role at Mower, Mr. Cheeks served in several key roles for a New York Governor including deputy director for legislative affairs and deputy press secretary. In addition, Mr. Cheeks provided communications support for several United States presidential candidates and served as a professional volunteer for the White House. Mr. Cheeks holds a Bachelor of Arts degree in Political Science from the State University of New York at Oswego and a Strategic Communications certificate from the Columbian College of Arts and Sciences at the George Washington University.
Job Titles:
- Senior Vice President and General Manager, ET
- Senior Vice President and General Manager, VIT
Scott entered AngioDynamics in 2005 as a sales representative serving the Carolinas. He served in a variety of positions, culminating in his most recent promotion to Sr. Vice President/General Manager of Vascular Interventions and Therapies and Peripheral Artery Disease.
Job Titles:
- Chief Financial Officer
- Executive Vice President
- Investor Relations Contact
- Member of the Management Team
Stephen A. Trowbridge was appointed Executive Vice President and Chief Financial Officer in February 2020, having served as Interim Chief Financial Officer since October 2019. Prior to his appointment as Chief Financial Officer, he served as the Company's Senior Vice President and General Counsel. He joined AngioDynamics in June 2008 as Corporate Counsel.
Prior to serving as the Company's CFO and managing its finance functions, Mr. Trowbridge managed the Legal function and supervised the Company's clinical affairs, medical affairs, and healthcare economics departments. Before joining AngioDynamics, Mr. Trowbridge served as Corporate Counsel at Philips Healthcare and Intermagnetics General Corporation.
Mr. Trowbridge began his career with Cadwalader, Wickersham & Taft LLP in the firm's Mergers and Acquisitions and Securities Group. Mr. Trowbridge received a Bachelor of Science in Science and Technology Studies from Rensselaer Polytechnic Institute, a Juris Doctor from the University of Pennsylvania Law School, and a Master of Business Administration from Duke University's Fuqua School of Business.
Job Titles:
- Senior Vice President of Quality and Regulatory Affairs
Warren G. Nighan joined AngioDynamics as the Senior Vice President of Quality and Regulatory Affairs in April 2017. Before joining AngioDynamics,…
Job Titles:
- Director
- Member of the Audit Committee
- Audit Committee
- Company 's Board of Director
Wesley E. Johnson Jr. joined the Company's Board of Director's in January 2007. From 2003-07, Mr. Johnson served as a member of the board of RITA Medical Systems Inc. Since February 2008, Mr. Johnson has served as President, Chief Executive Officer and director of Cardiokinetix Inc., a developer of medical devices for the treatment of congestive heart failure. From October 2005 to February 2008 he served as General Manager of Abbott Spine S.A., a division of Abbott Laboratories. From June 2003 to October 2005, Mr. Johnson served as Division Vice President, Finance for Abbott Spine. From May 1999 to June 2003 he served as Vice President of Operations and Chief Financial Officer for Spinal Concepts. Mr. Johnson has a B.B.A. in accounting from Texas A&M University and became a Certified Public Accountant in 1981.
Member of the Audit Committee
Chair of the Nominating, Compliance, and Corporate Governance Committee